Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Tumor Angiogenesis”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 15 of 0 results

Early research (Phase 1)Study completedNCT00072111
What this trial is testing

Anakinra in Treating Patients With Metastatic Cancer Expressing the Interleukin-1 Gene

Who this might be right for
Unspecified Adult Solid Tumor, Protocol Specific
National Cancer Institute (NCI)
Post-approval studies (Phase 4)Study completedNCT02497118
What this trial is testing

Recombinant Human Endostatin Combined With NP in Neoadjuvant Chemotherapy of Stage ⅢA NSCLC

Who this might be right for
Non Small Cell Lung Cancer
Tianjin Medical University Cancer Institute and Hospital 30
Testing effectiveness (Phase 2)Study completedNCT00001446
What this trial is testing

Phase II Study of Oral Thalidomide in Patients With Hormone-Refractory Prostate Cancer

Who this might be right for
Prostatic Neoplasm
National Cancer Institute (NCI) 64
Early research (Phase 1)UnknownNCT02970786
What this trial is testing

Phase I Trial: 68Ga-NODAGA-E(c[RGDyK])2 Positron Emission Tomography for Imaging Angiogenesis in Primary and Metastatic Tumor Lesions in Humans

Who this might be right for
Neuroendocrine CarcinomaBreast CancerOvarian Cancer
Rigshospitalet, Denmark 10
Not applicableEnded earlyNCT01336231
What this trial is testing

Impact on Quality of Life, Fatigue and Cognitive Function in Anti-angiogenesis in Patients With Metastatic Kidney Cancer

Who this might be right for
Metastatic Kidney Cancer
Centre Francois Baclesse 82
Not applicableStudy completedNCT04974983
What this trial is testing

Impact of Bevacizumab on Symptom Burden and Neurological Deficits in Patients With Recurrent Glioblastoma

Who this might be right for
GlioblastomaAngiogenesis
University Hospital Regensburg 203
Not applicableStudy completedNCT05208931
What this trial is testing

Development of an Optimal Algorithm for the Management of Patients With Retinal Pigment Epithelium Detachment in Neovascular Age-related Macular Degeneration Using Artificial Intelligence

Who this might be right for
Neovascular Age-related Macular Degeneration
The S.N. Fyodorov Eye Microsurgery State Institution 300
Testing effectiveness (Phase 2)UnknownNCT00684970
What this trial is testing

Phase IIB Clinical Trial of Hamsa-1™ in Metastatic Castration Resistant Prostate Cancer (CRPC)

Who this might be right for
Metastatic Castration Resistant Prostate Cancer (CRPC)
Tiltan Pharma Ltd. 100
Testing effectiveness (Phase 2)Study completedNCT00094094
What this trial is testing

Anti-angiogenesis Agent AG-013736 in Patients With Advanced Non-Small Cell Lung Cancer

Who this might be right for
Lung NeoplasmsCarcinoma, Non-small Cell Lung
Pfizer 32
Early research (Phase 1)Study completedNCT00314366
What this trial is testing

Intramyocardial Injection of Autologous Aldehyde Dehydrogenase-Bright Stem Cells for Therapeutic Angiogenesis (FOCUS Br)

Who this might be right for
Coronary Artery Disease
Texas Heart Institute 21
Not applicableStudy completedNCT01978977
What this trial is testing

Maintenance Bevacizumab or Observation After Taxane Based First Line Chemotherapy In Metastatic Breast Cancer

Who this might be right for
Metastatic Breast Cancer
Hellenic Oncology Research Group 400
Testing effectiveness (Phase 2)Study completedNCT05263245
What this trial is testing

The Pharmacological Effects of Using Cabozantinib With a Light Breakfast

Who this might be right for
Renal Cell Carcinoma
dr. Tom van der Hulle 12
Not applicableStudy completedNCT01341171
What this trial is testing

The Impact of Tamoxifen and Aromatase Inhibitors on Platelet Proteins

Who this might be right for
Breast Cancer
University of Vermont 30
Testing effectiveness (Phase 2)Ended earlyNCT00131651
What this trial is testing

ATN-161 in Advanced Renal Cell Cancer

Who this might be right for
Carcinoma, Renal Cell
Attenuon 36
Early research (Phase 1)Study completedNCT02572687
What this trial is testing

Ramucirumab (LY3009806) Plus MEDI4736 in Participants With Advanced Gastrointestinal or Thoracic Malignancies

Who this might be right for
Gastric CancerGastroesophageal Junction AdenocarcinomaNon-Small Cell Lung Cancer+1 more
Eli Lilly and Company 85